Streamline Regulatory Writing with GenAI White Paper Streamline Regulatory Writing with GenAI 探索定制化 AI 解决方案如何简化和优化监管文件撰写,从而提升效率、准确性与合规性。Certara2024 年 11 月 14 日
Enhancing Pharmacokinetics Workflows at Charles River Case Study 优化 Charles River 实验室的药代动力学工作流程 PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…Certara2024 年 11 月 13 日
4 Ways to Optimize Agency Partnerships Using a Platform-Oriented Approach Blog 使用平台导向法优化机构合作关系的 4 种方法 In the pharmaceutical and medical devices industries, the journey from product development to market introduction…Certara2024 年 11 月 8 日
Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody Publication 通过对重组人单克隆抗体进行靶向药物处置建模和模拟,为妊娠剂量提供依据 The article titled "Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a…Certara2024 年 11 月 4 日
Part 5: Regulatory Outlook on Data Management Video 第 5 部分:Regulatory Outlook on Data Management In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…Certara2024 年 10 月 31 日
Part 4: Consequences of Improper Data Collection Video 第 4 部分:Consequences of Improper Data Collection In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…Certara2024 年 10 月 31 日
Part 3: Ensuring Proper Data Collection Video 第 3 部分:Ensuring Proper Data Collection In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…Certara2024 年 10 月 31 日
Part 2: Regulatory Challenges With Data Collection Video 第 2 部分:Regulatory Challenges With Data Collection In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…Certara2024 年 10 月 31 日
Part 1: Complexities in Data Collection Video 第 1 部分:数据收集的复杂性 In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…Certara2024 年 10 月 31 日
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women Publication Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women The article titled "Using PBPK modeling to supplement clinical data and support the safe and…Certara2024 年 10 月 30 日